EBS 营业利润历史(2016–2025)
EMERGENT BIOSOLUTIONS INC. (EBS) 年度营业利润历史(来自 SEC 财报)—— 每个财年的申报值。
$100.1MFY2025 · FY2016 以来:$105.5M → $100.1M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $100.1M | +192.1% |
| FY2024 | -$108.7M | +85.0% |
| FY2023 | -$726.4M | -327.3% |
| FY2022 | -$170.0M | -149.8% |
| FY2021 | $341.4M | -22.1% |
| FY2020 | $438.5M | +284.3% |
| FY2019 | $114.1M | +27.1% |
| FY2018 | $89.8M | -27.8% |
| FY2017 | $124.3M | +17.8% |
| FY2016 | $105.5M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议